S

Structure Therapeutics

54 employees

Structure Therapeutics specializes in the discovery and development of drugs against a type of targets called GPCR.

Basic info

Industry

biotechnology research

Sectors

Biotechnology

Cardiovascular Diseases

Health Care

Product Research

Metabolic Diseases

Medical

Pharmaceutical

Diabetes

Pulmonary

Computational Chemistry

Date founded

2017

Funding rounds raised

Total raised

$100M

from 11 investors over 11 rounds

S

Structure Therapeutics raised $100M on October 20, 2021

Investors: TCG X, 泰福资本 TF Capital, Qiming Venture Partners, Surveyor Capital, WuXi AppTec, Sequoia Capital China, Stork Capital S.à.r.l. and Woodline Partners LP

S

Structure Therapeutics raised $26M on March 11, 2020

Investors: Qiming Venture Partners

S

Structure Therapeutics raised $16M on April 1, 2019

Investors: Qiming Venture Partners and F-Prime Capital Partners